BPC-157 and TB-500 are two of the most frequently studied compounds in tissue-repair peptide research — and two of the most frequently confused. They come from different source proteins, act through different mechanisms, and occupy different corners of the preclinical literature, yet they appear together in research contexts so often that “BPC-157 and TB-500” has become a research topic in its own right. This guide covers what each peptide is, how they differ, and why the research literature so often examines them side by side.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a stable fragment of 15 amino acids derived from a protective protein identified in gastric juice. Its unusual stability is one reason it became a laboratory staple: unlike many peptides, BPC-157 resists degradation in acidic conditions, which made it practical to study across a wide range of experimental models.
In the preclinical literature, BPC-157 is studied primarily in tissue-repair contexts — tendon, ligament, muscle and gastrointestinal models — where research has focused on its interaction with local growth-factor signalling and angiogenesis pathways.
TB-500 is the research name for synthetic thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide present in nearly all cell types. Its best-characterised role in the literature is as a major actin-binding molecule — actin being the cytoskeletal protein that drives cell movement and structure.
Because cell migration sits at the centre of tissue-repair biology, thymosin beta-4 appears across a broad preclinical literature spanning wound-repair models, cardiac and corneal tissue research, and cell-migration studies. It has also drawn interest in dermal-papilla and hair-follicle research — covered in our article on TB-500 and hair-growth research.
Although both peptides appear in tissue-repair research, they are not interchangeable and are not related molecules:
A common point of confusion: TB-500 is sometimes mixed up with Thymosin Alpha-1. Despite the shared “thymosin” name, Thymosin Alpha-1 is a different peptide entirely, studied in immune-signalling research rather than tissue repair.
The two peptides’ mechanisms are complementary rather than overlapping — one body of research examines localized repair and blood-vessel signalling, the other examines the cellular machinery of migration into damaged tissue. Because both threads matter in tissue-repair biology, experimental designs frequently include both compounds, and the combination has become one of the most-referenced pairings in the research-peptide literature.
For researchers sourcing both compounds, the practical considerations are the same as for any research peptide: verified purity, batch-level testing, and correct handling.
Both peptides are supplied as lyophilized powders and follow the same handling profile: store sealed at -20°C for long-term stability (2–8°C short-term), reconstitute with bacteriostatic water, and store reconstituted solutions at 2–8°C while avoiding repeated freeze-thaw cycles. Our reconstitution calculator covers concentration calculations for laboratory preparation.
No. BPC-157 is a 15-amino-acid pentadecapeptide derived from a gastric-juice protein; TB-500 is synthetic thymosin beta-4, a 43-amino-acid actin-binding peptide. They are unrelated molecules studied for different mechanisms.
Their studied mechanisms are complementary — local growth-factor and angiogenesis signalling for BPC-157, actin-mediated cell migration for TB-500 — so tissue-repair research designs frequently examine both.
Both are stored as sealed lyophilized powders at -20°C long-term or 2–8°C short-term. After reconstitution with bacteriostatic water, store at 2–8°C and avoid repeated freeze-thaw cycles.
Yes. Every batch is independently tested by HPLC and mass spectrometry to ≥99% purity, with a lot-matched Certificate of Analysis available for each batch.
For research purposes only. Not for human consumption. This material and information are intended exclusively for in-vitro laboratory and preclinical research applications conducted by qualified personnel.
